Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
LIVE coverage of the 2024 Rose Parade is dedicated to Tammy, in recognition and appreciation for all that she achieved supporting cowgirls everywhere.
Both imports and exports are moving through the Panama Canal at a slower pace as the ag industry continues to deal with drought-related restrictions.
A glimpse into the mindset of the University of Kentucky’s trio of arborists as they relish their role in fostering healthy urban spaces across campus.
Getting strange calls or texts from “Amazon” after placing holiday gift orders? In this AARP Live Minute, experts from AARP reveal three Amazon imposter scams to watch out for as you navigate the holiday season.
